SG131765A1 - New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- SG131765A1 SG131765A1 SG200306491-2A SG2003064912A SG131765A1 SG 131765 A1 SG131765 A1 SG 131765A1 SG 2003064912 A SG2003064912 A SG 2003064912A SG 131765 A1 SG131765 A1 SG 131765A1
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- new
- pharmaceutical compositions
- compositions containing
- carbazole compounds
- Prior art date
Links
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212847A FR2845996A1 (fr) | 2002-10-16 | 2002-10-16 | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG131765A1 true SG131765A1 (en) | 2007-05-28 |
Family
ID=29725330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200306491-2A SG131765A1 (en) | 2002-10-16 | 2003-10-16 | New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7151108B2 (xx) |
| EP (1) | EP1411057B1 (xx) |
| JP (1) | JP2004277404A (xx) |
| KR (1) | KR100502250B1 (xx) |
| CN (1) | CN1241925C (xx) |
| AR (1) | AR041618A1 (xx) |
| AT (1) | ATE294181T1 (xx) |
| AU (1) | AU2003254746A1 (xx) |
| BR (1) | BR0304575A (xx) |
| CA (1) | CA2443585A1 (xx) |
| DE (1) | DE60300571T2 (xx) |
| DK (1) | DK1411057T3 (xx) |
| EA (1) | EA007250B1 (xx) |
| ES (1) | ES2240927T3 (xx) |
| FR (1) | FR2845996A1 (xx) |
| HK (1) | HK1063321A1 (xx) |
| MA (1) | MA27007A1 (xx) |
| MX (1) | MXPA03009362A (xx) |
| MY (1) | MY134620A (xx) |
| NO (1) | NO20034614L (xx) |
| NZ (1) | NZ528902A (xx) |
| PL (1) | PL362885A1 (xx) |
| PT (1) | PT1411057E (xx) |
| SG (1) | SG131765A1 (xx) |
| SI (1) | SI1411057T1 (xx) |
| ZA (1) | ZA200308053B (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| US7846945B2 (en) | 2007-03-08 | 2010-12-07 | Lexicon Pharmaceuticals, Inc. | Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use |
| US9758505B2 (en) | 2014-02-12 | 2017-09-12 | Iteos Therapeutics | 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| CN103804278B (zh) * | 2014-02-19 | 2016-04-13 | 西北大学 | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 |
| UY36122A (es) * | 2014-05-15 | 2016-01-08 | Iteos Therapeutics | ?derivados de pirrolidina-2,5-diona, composiciones farmacéuticas y métodos para usar como inhibidores ido1? |
| SG11201706992TA (en) | 2015-03-17 | 2017-09-28 | Pfizer | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| JP2016216446A (ja) * | 2015-05-14 | 2016-12-22 | ファイザー・インク | ピロリジン−２，５−ジオン誘導体の多形形態、医薬組成物、およびｉｄｏ１阻害薬としての使用方法 |
| CA2994917A1 (en) | 2015-08-10 | 2017-02-16 | Pfizer Inc. | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3010675B2 (ja) * | 1989-03-23 | 2000-02-21 | 萬有製薬株式会社 | 抗腫瘍性物質ｂｅ―１３７９３ｃ |
-
2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
-
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 EP EP03292545A patent/EP1411057B1/fr not_active Expired - Lifetime
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active IP Right Cessation
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
-
2004
- 2004-08-13 HK HK04106087A patent/HK1063321A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR041618A1 (es) | 2005-05-26 |
| MA27007A1 (fr) | 2004-12-20 |
| ES2240927T3 (es) | 2005-10-16 |
| ATE294181T1 (de) | 2005-05-15 |
| PL362885A1 (en) | 2004-04-19 |
| CN1496989A (zh) | 2004-05-19 |
| DE60300571T2 (de) | 2006-02-23 |
| KR100502250B1 (ko) | 2005-07-20 |
| US7151108B2 (en) | 2006-12-19 |
| CA2443585A1 (fr) | 2004-04-16 |
| EA200301020A1 (ru) | 2004-04-29 |
| EP1411057B1 (fr) | 2005-04-27 |
| US20040077672A1 (en) | 2004-04-22 |
| NO20034614D0 (no) | 2003-10-15 |
| EA007250B1 (ru) | 2006-08-25 |
| KR20040034472A (ko) | 2004-04-28 |
| FR2845996A1 (fr) | 2004-04-23 |
| CN1241925C (zh) | 2006-02-15 |
| DE60300571D1 (de) | 2005-06-02 |
| NO20034614L (no) | 2004-04-19 |
| AU2003254746A1 (en) | 2004-05-06 |
| ZA200308053B (en) | 2004-07-08 |
| MY134620A (en) | 2007-12-31 |
| HK1063321A1 (en) | 2004-12-24 |
| DK1411057T3 (da) | 2005-08-29 |
| SI1411057T1 (xx) | 2005-08-31 |
| MXPA03009362A (es) | 2004-04-28 |
| JP2004277404A (ja) | 2004-10-07 |
| EP1411057A1 (fr) | 2004-04-21 |
| BR0304575A (pt) | 2004-07-20 |
| NZ528902A (en) | 2004-09-24 |
| PT1411057E (pt) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1042698B (zh) | 新的二苯脲化合物、其製備方法和含有該化合物的藥物組合物 | |
| HUP0105108A3 (en) | Amide compounds, process for their preparation and pharmaceutical compositions containing them | |
| HK1039117B (zh) | 新的哌啶-4-磺酰胺化合物、其製備方法和含有它們的藥物組合物 | |
| HUP0203976A3 (en) | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them | |
| HUP0104272A3 (en) | New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG131765A1 (en) | New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
| AU2003231920A8 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| HK1071748A1 (en) | New heterocyclic oxime compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them | |
| HUP0000308A2 (en) | New cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1049159B (zh) | 新的茚並吲哚酮化合物，其製備方法和含有這種化合物的藥物組合物 | |
| HK1049000B (zh) | 異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物 | |
| IL147069A0 (en) | Novel benzene derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| EG24369A (en) | New isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HU0105328D0 (en) | Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1053646A1 (en) | BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0004543A3 (en) | Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them | |
| HK1040247A1 (zh) | 新穎的環丁烷並吲羧酰胺化合物、其製備方法和含有它們的藥物組合物 | |
| SG146431A1 (en) | New benzo[a]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
| PL375956A1 (en) | Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same | |
| HK1079775A1 (en) | New 4-oxo-4,6,7,8-tetrahydro-pyrrolo Ä1,2-AÜpyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG113482A1 (en) | New imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1057368A1 (en) | New indoline compounds, a process for their preparation and pharmaceutical compositions containing them. |